NCT05894642

Brief Summary

Justification: among the sequelae of Covid-19 in clinical practice we frequently find persistent neuromusculoskeletal pain. Prevalence data and the underlying mechanisms of such pain are very limited in the scientific literature. Therefore, with this research we will try to answer these questions. Main objective: to determine and characterize persistent musculoskeletal pain in Covid-19 patients. Method: two phases. First, a descriptive cross-sectional study will be carried out to estimate the prevalence of Long Covid Pain (LCP). Second phase, a case-control study will be carried out using the sample obtained in the first phase as the population. The sample will be divided into two groups: post-Covid-19 patients with LCP and post-Covid-19 patients without persistent pain (control group). The two groups will be matched according to sex, age and level of severity of the pathology. An assessment and comparison between groups will be made of the following variables: central sensitization, healthy physical condition and blood test values, which will be evaluated by means of physical examination, questionnaires and laboratory tests. Applicability of the results: this is a pioneering project at the national level, which would determine more reliably the prevalence of LCP in postcovid and could be a first step in the search for the best therapeutic strategies for these patients. This would help to improve the quality of life of these patients and to better manage the social and healthcare resources used in their treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2022

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

June 6, 2023

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 8, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
Last Updated

June 8, 2023

Status Verified

June 1, 2023

Enrollment Period

1.5 years

First QC Date

June 6, 2023

Last Update Submit

June 7, 2023

Conditions

Keywords

Long COVIDChronic PainMusculoskeletal painPrimary health carePsychological factors

Outcome Measures

Primary Outcomes (1)

  • Quality of life (QoL)

    EQ-5D questionnaire (Qualitave of Life 5 Dimension): The EQ-5D-3L is a brief multi-attribute health status measure composed of five questions with Likert response options (descriptive system) and a visual analogue scale (EQ-VAS). The descriptive system covers five dimensions of health (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) with three levels of severity in each dimension (no problems, some problems, and extreme problems).

    1 day

Secondary Outcomes (4)

  • Pain Intensity

    1 day

  • Areas of pain

    1 day

  • Quantitative sensory tests

    1 day

  • Handgrip Strength assessment

    1 day

Study Arms (2)

Long Covid Pain Patients

Behavioral: 0

Control Group, healthy people

Patients that had had Covid-19 but did not developed chronic pain or other chronic symptoms.

Interventions

0BEHAVIORAL

It is a case-control study, cross-sectional, so there is no intervention possible.

Long Covid Pain Patients

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Long Covid Pain Patients

You may qualify if:

  • Patients who have had Covid-19, with a confirmatory PCR+ test or positive antigen test and recorded in their primary care medical record.
  • Subjects between 18-70 years old.
  • Musculoskeletal pain of more than 12 weeks of evolution since the beginning of the infection.
  • Agree to participate in the study and sign the informed consent form.

You may not qualify if:

  • History of chronic musculoskeletal pain of more than 12 weeks of evolution prior to Covid-19.
  • History of diagnosed major depression.
  • Having a diagnosis of fibromyalgia prior to Covid-19 infection.
  • Pregnancy.
  • Pain of oncologic origin.
  • Fracture or surgical intervention on the spine in the last year.
  • Bladder or bowel incontinence.
  • Saddle anesthesia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad de Valladolid

Valladolid, 47005, Spain

RECRUITING

MeSH Terms

Conditions

Post-Acute COVID-19 SyndromeChronic PainMusculoskeletal Pain

Condition Hierarchy (Ancestors)

COVID-19Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesPost-Infectious DisordersChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsMuscular DiseasesMusculoskeletal Diseases

Central Study Contacts

Federico Montero Cuadrado

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Phd Candidate

Study Record Dates

First Submitted

June 6, 2023

First Posted

June 8, 2023

Study Start

May 15, 2022

Primary Completion

December 1, 2023

Study Completion

February 1, 2024

Last Updated

June 8, 2023

Record last verified: 2023-06

Locations